Australia's most trusted
source of pharma news
Thursday, 11 September 2025
Posted 9 September 2025 AM
Money spent by industry on HCPs has dropped overall with Pfizer taking the crown as the biggest spender over the most recent six-month reporting period, followed by AstraZeneca and Novartis in third place.
The results were tight, with Pfizer forking out $899,562. AstraZeneca wasn't far behind on $891,797 while Novartis spent $849,230.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.